Similar articles

• [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].

  Rüttinger H, Hermes M. Rüttinger H, et al. Nervenarzt. 1990 Jun;61(6):356-60. Nervenarzt. 1990. PMID: 2377261 German. No abstract available.
• Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.

  Gonzalez-Scarano F, Grossman RI, Galetta S, Atlas SW, Silberberg DH. Gonzalez-Scarano F, et al. Ann Neurol. 1987 Mar;21(3):300-6. doi: 10.1002/ana.410210312. Ann Neurol. 1987. PMID: 3606036
• [Progress of research in the diagnosis of multiple sclerosis by study of the cerebrospinal fluid].

  Schmidt RM, Kuppe G, Kissig B, Ludewig R, Neumann V. Schmidt RM, et al. Psychiatr Neurol Med Psychol (Leipz). 1987 Nov;39(11):651-61. Psychiatr Neurol Med Psychol (Leipz). 1987. PMID: 2450384 German.
• [Magnetic resonance imaging of disseminated sclerosis].

  Christiansen AP, Wanscher B, Larsson HB, Henriksen O. Christiansen AP, et al. Ugeskr Laeger. 1994 Oct 24;156(43):6348-52. Ugeskr Laeger. 1994. PMID: 7810007 Review. Danish.
• Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis.

  Thompson EJ, Freedman MS. Thompson EJ, et al. Adv Neurol. 2006;98:147-60. Adv Neurol. 2006. PMID: 16400832 Review. No abstract available.